GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $8,469,972,000 | -17.4% | 184,250 | -3.9% | 1.79% | -21.8% |
| Q2 2014 | $10,252,383,000 | -0.6% | 191,705 | -0.7% | 2.28% | -3.3% |
| Q1 2014 | $10,314,929,000 | -2.1% | 193,055 | -2.2% | 2.36% | -2.9% |
| Q4 2013 | $10,535,449,000 | +107022.0% | 197,330 | +0.6% | 2.43% | -8.8% |
| Q3 2013 | $9,835,000 | -1.4% | 196,090 | -1.8% | 2.67% | -1.8% |
| Q2 2013 | $9,976,000 | – | 199,625 | – | 2.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |